Pharma BD Deal Intelligence
Ranks computed across 828 graded deals (Critic + Outcome Score both present).
Pharmacia & Upjohn and Monsanto merged in a $27 billion stock-for-stock merger of equals, creating Pharmacia Corporation with a combined market capitalization exceeding $50 billion. Each Pharmacia share was exchanged for 1.19 shares and each Monsanto share for 1 share of the new entity. The agricultural division was later spun off as a separate Monsanto.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Pharmacia & Upjohn Inc. / Monsanto Company (this deal) | 1999 | $27.0B | 64 |
| Amgen Inc. / Immunex Corporation | 2002 | $16.0B | 92 |
| PerkinElmer, Inc. / EUROIMMUN Medizinische Labordiagnostika AG | 2017 | $1.3B | 88 |
| Vertex Pharmaceuticals Incorporated / Alpine Immune Sciences | 2024 | $4.9B | 78 |
| Roche Holding AG / Genentech, Inc. (Roche Group) | 2009 | $46.8B | 72 |
| Travere Therapeutics, Inc. / Everest Medicines Limited | 2026 | $1.1B | 72 |
| Amgen Inc. / Horizon Therapeutics plc | 2022 | $27.8B | 72 |
← Browse all deals · How we score deals
More: 1999 deals · Immunology deals